Tag: PREVENT IV study

Corgentech and Bristol-Myers Squibb Announce E2F Decoy Trial Results

Corgentech, and Bristol-Myers Squibb Company announced top-line results from PREVENT IV, a Phase 3 clinical trial evaluating the use of…